Analysis of survival outcomes using likelihood ratio test in trials incorporating patient's treatment choice

© 2023 Informa UK Limited, trading as Taylor & Francis Group.

Détails bibliographiques
Publié dans:Journal of applied statistics. - 1991. - 51(2024), 7 vom: 18., Seite 1344-1358
Auteur principal: Chahine, Rouba A (Auteur)
Autres auteurs: Aban, Inmaculada
Format: Article en ligne
Langue:English
Publié: 2024
Accès à la collection:Journal of applied statistics
Sujets:Journal Article Likelihood function censoring clinical trial designs preference survival treatment choice
LEADER 01000caa a22002652c 4500
001 NLM373240252
003 DE-627
005 20250306064829.0
007 cr uuu---uuuuu
008 240605s2024 xx |||||o 00| ||eng c
024 7 |a 10.1080/02664763.2023.2199177  |2 doi 
028 5 2 |a pubmed25n1243.xml 
035 |a (DE-627)NLM373240252 
035 |a (NLM)38835828 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Chahine, Rouba A  |e verfasserin  |4 aut 
245 1 0 |a Analysis of survival outcomes using likelihood ratio test in trials incorporating patient's treatment choice 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Revised 07.06.2024 
500 |a published: Electronic-eCollection 
500 |a Citation Status PubMed-not-MEDLINE 
520 |a © 2023 Informa UK Limited, trading as Taylor & Francis Group. 
520 |a Methods for designing and analyzing multiple arms survival trials that incorporate patient's treatment choice are needed. In these trials, patients are randomized into two groups, random and choice. Participants in the choice group choose their treatment, which is not a current standard practice in randomized clinical trials. In this paper, we propose a new method based on the likelihood function to design and analyze these trials with time to event outcomes in the presence of non-informative right censoring. We use simulations to evaluate the methods for Weibull outcomes, complete and censored. Finally, we provide an illustration for designing a study in which we discuss some design considerations and demonstrate the methods 
650 4 |a Journal Article 
650 4 |a Likelihood function 
650 4 |a censoring 
650 4 |a clinical trial designs 
650 4 |a preference 
650 4 |a survival 
650 4 |a treatment choice 
700 1 |a Aban, Inmaculada  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Journal of applied statistics  |d 1991  |g 51(2024), 7 vom: 18., Seite 1344-1358  |w (DE-627)NLM098188178  |x 0266-4763  |7 nnas 
773 1 8 |g volume:51  |g year:2024  |g number:7  |g day:18  |g pages:1344-1358 
856 4 0 |u http://dx.doi.org/10.1080/02664763.2023.2199177  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 51  |j 2024  |e 7  |b 18  |h 1344-1358